tiprankstipranks
PMV Pharmaceuticals (PMVP)
NASDAQ:PMVP
US Market

PMV Pharmaceuticals (PMVP) Financial Statements

81 Followers

PMV Pharmaceuticals Financial Overview

PMV Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.322; its P/E ratio is -1.18; PMV Pharmaceuticals is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -18.22M$ -18.90M$ -19.62M$ -20.13M$ -21.45M
EBITDA$ -17.86M$ -18.54M-$ 0.00$ 0.00
Net Income Common Stockholders$ -15.27M$ -15.76M$ -16.64M$ -17.44M$ -19.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 197.94M$ 203.06M$ 201.92M$ 187.91M$ 230.26M
Total Assets$ 236.88M$ 252.15M$ 261.03M$ 242.22M$ 253.96M
Total Debt$ 13.02M$ 13.29M$ 12.70M$ 12.98M$ 13.48M
Net Debt$ -184.92M$ -189.77M$ -189.22M$ -174.93M$ -216.78M
Total Liabilities$ 24.20M$ 26.46M$ 23.41M$ 24.41M$ 23.79M
Stockholders Equity$ 212.68M$ 225.69M$ 237.61M$ 217.81M$ 230.17M
Cash Flow-
Free Cash Flow$ -16.78M$ -12.28M---
Operating Cash Flow$ -16.18M$ -12.09M$ -15.66M--
Investing Cash Flow$ 26.17M$ -2.59M$ -33.64M--
Financing Cash Flow-$ 288.00K$ 33.15M--
Currency in USD

PMV Pharmaceuticals Earnings and Revenue History

PMV Pharmaceuticals Debt to Assets

PMV Pharmaceuticals Cash Flow

PMV Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis